Angiogenic factors such as vascular endothelial growth factor (VEGF) are crucial for the development of choroidal neovascularization (CNV), and anti-VEGF compounds are an effective AMD treatment [3]. This evidence concerns the gene VEGFA and choroidal neovascularization.